Search

The article discusses the need for enhanced surveillance and response strategies for arbovirus outbreaks in Italy. It highlights factors contributing to the reemergence of arboviruses, such as viral adaptation, climate change, and increased population mobility. The article introduces ArboItaly, a centralized repository that consolidates epidemiological data and integrates information on different hosts to facilitate the identification of trends and improve control measures. It emphasizes the importance of international collaboration, genomic surveillance, and proactive approaches in managing the evolving threat of arboviruses. The document is a list of references for scientific articles related to arboviral diseases, providing a range of perspectives and research findings on topics such as transmission dynamics, surveillance systems, control methods, and the impact of environmental factors on disease spread. [Extracted from the article]

The article discusses the new SARS-CoV-2 variant KP.3.1.1 and its genetic potential. The variant has been spreading and causing concern due to its increasing prevalence worldwide. The variant carries several mutations in the spike protein, including F456L, Q493E, and V1104L, which may contribute to immune evasion and increased transmissibility. However, the article emphasizes that the variant does not currently pose an immediate increased risk and is not an unusually worrisome variant. Ongoing monitoring of SARS-CoV-2 variants is important to prevent unforeseen outbreaks. [Extracted from the article]

Despite Parvovirus B19 (B19V) generally causing mild or asymptomatic infections, and only certain high-risk groups such as hematological or immunocompromised patients and pregnant women tending to develop complications, several factors challenge the assumption of a "benign" clinical course in immunocompetent adults and adolescents. A significant proportion of the population may harbor undiagnosed health conditions or genetic predispositions that could render them more susceptible to severe B19V complications. These could include mild hematological disorders, immune dysregulation not resulting in overt immunodeficiency, or underlying cardiac conditions. Concurrent infections with other pathogens, even seemingly minor ones, could synergistically increase the severity of B19V infection, leading to more pronounced clinical manifestations. While not definitively proven, the possibility of emerging B19V strains with increased virulence or altered tissue tropism cannot be entirely discounted. Additionally, the period of pandemic-related restrictions likely led to reduced B19V circulation, potentially resulting in a cohort of young adults with limited natural immunity, making them more vulnerable to infection. Potential clinical consequences include atypical and severe presentations, even in individuals without known risk factors. The traditional focus on B19V primarily as a pediatric concern might lead to underdiagnosis or delayed diagnosis in adults, potentially hindering timely intervention and management. A surge in B19V-related complications, even if individually mild, could collectively strain healthcare resources, particularly in settings with limited capacity or pre-existing pressures. Possible recommendations are to heighten clinical awareness with a high index of suspicion for B19V infection in adults and adolescents presenting with compatible symptoms, even in the absence of classic risk factors. Additionally, expanding testing criteria and enhancing public health surveillance efforts would be prudent. [ABSTRACT FROM AUTHOR]

From 1 January 2022 to 31 May 2024, the World Health Organization (WHO) reported 97,745 laboratory-confirmed Mpox cases, including 203 deaths, across 116 countries. Despite a 2.3% decrease in new cases in May 2024 compared to April 2024, significant regional variations persist. The African Region reported the highest proportion of new cases, while other regions experienced mixed trends. Phylogenomic analyses of the Mpox virus Clade IIb lineage B.1 reveal stable genetic variability with minimal diversification. The Bayesian Skyline Plot indicates a generally stable viral population size with a modest peak in late 2023, followed by a decline. In general, the data indicate that the MPXV outbreak is primarily localized within a few consistent geographic clusters. The virus's evolution is relatively slow, as indicated by its stable genetic variability, and Clade IIb lineage B.1 does not currently show signs of rapid genetic changes or population growth. The current low level of genetic diversity should not lead to complacency. Ongoing genomic surveillance is essential for effective outbreak management and understanding. This monitoring is crucial for identifying any shifts in the virus's behavior or transmission, allowing for prompt public health responses and adjustments. In addition, continued vigilance is necessary to detect any new variants that might influence the outbreak's trajectory. [ABSTRACT FROM AUTHOR]

Viral hepatitis is a major cause of liver illness worldwide. Despite advances in the understanding of these infections, the pathogenesis of hepatitis remains a complex process driven by intricate interactions between hepatitis viruses and host cells at the molecular level. This paper will examine in detail the dynamics of these host–pathogen interactions, highlighting the key mechanisms that regulate virus entry into the hepatocyte, their replication, evasion of immune responses, and induction of hepatocellular damage. The unique strategies employed by different hepatitis viruses, such as hepatitis B, C, D, and E viruses, to exploit metabolic and cell signaling pathways to their advantage will be discussed. At the same time, the innate and adaptive immune responses put in place by the host to counter viral infection will be analyzed. Special attention will be paid to genetic, epigenetic, and environmental factors that modulate individual susceptibility to different forms of viral hepatitis. In addition, this work will highlight the latest findings on the mechanisms of viral persistence leading to the chronic hepatitis state and the potential implications for the development of new therapeutic strategies. Fully understanding the complex host–pathogen interactions in viral hepatitis is crucial to identifying new therapeutic targets, developing more effective approaches for treatment, and shedding light on the mechanisms underlying progression to more advanced stages of liver damage. [ABSTRACT FROM AUTHOR]

Avian influenza A(H5N1) viruses can infect humans and cause a range of illnesses, from mild respiratory infections to severe diseases that can be fatal. Human infections are typically acquired through direct contact with infected animals or contaminated environments. Recent outbreaks of avian influenza have been documented in various countries, including Cambodia, Australia, Vietnam, and the United States. While there have been cases of human infection from exposure to infected cows, genetic analysis suggests that the viruses have not yet specialized towards the human host. Continuous surveillance and monitoring are crucial to detect any genetic changes that may indicate a genuine spill-over event. [Extracted from the article]

The COVID-19 pandemic underscored the critical importance of vaccination to global health security and highlighted the potential of digital health solutions to improve immunization strategies. This article explores integrating digital health technologies with immunization programs to improve coverage, monitoring, and public health outcomes. It examines the current landscape of digital tools used in immunization initiatives, such as mobile health apps, electronic health records, and data analytics platforms. Case studies from different regions demonstrate the effectiveness of these technologies in addressing challenges such as vaccine hesitancy, logistics, and real-time monitoring of vaccine distribution and adverse events. The paper also examines ethical considerations, data privacy issues, and the need for a robust digital infrastructure to support these innovations. By analyzing the successes and limitations of digital health interventions in immunization campaigns during and after the COVID-19 pandemic, we provide recommendations for future integration strategies to ensure resilient and responsive immunization systems. This research aims to guide policymakers, health professionals, and technologists in leveraging digital health to strengthen immunization efforts and prepare for future public health emergencies. [ABSTRACT FROM AUTHOR]

Background: Influenza viruses are etiological agents which cause contagious respiratory, seasonal epidemics and, for influenza A subtypes, pandemics. The clinical picture of influenza has undergone continuous change over the years, due to intrinsic viral evolution as well as "reassortment" of its genomic segments. The history of influenza highlights its ability to adapt and to rapidly evolve, without specific circumstances. This reflects the complexity of this pathology and poses the fundamental question about its assumption as a "common illness" and its impact on public health. Summary: The global influenza epidemics and pandemics claimed millions of deaths, leaving an indelible mark on public health and showing the need for a better comprehension of the influenza virus. The clear understanding of genetic variations during the influenza seasonal epidemics is a crucial point for developing effective strategies for prevention, treatment, and vaccine design. The recent advance in next-generation sequencing approaches, model systems to virus culture, and bioinformatics pipeline played a key role in the rapid characterization of circulating influenza strains. In particular, the increase in computational power allowed the performance of complex tasks in healthcare settings through machine learning algorithms, which analyze different variables, such as medical and laboratory outputs, to optimize medical research and improve public health systems. The early detection of emerging and reemerging pathogens is a matter of importance to prevent future pandemics. Key Messages: The perception of influenza as a "trivial flu" or a more serious public health concern is a subject of ongoing debate, reflecting the multifaceted nature of this infectious disease. The variability in the severity of influenza sheds light on the unpredictability of the viral characteristics, coupled with the challenges in accurately predicting circulating strains. This adds complexity to the public health burden of influenza and highlights the need for targeted interventions. [ABSTRACT FROM AUTHOR]

Background: This multicentric prospective study was carried out at Fondazione Policlinico Universitario Campus Bio Medico and Ospedale di Stato of St. Marino Republic. Between 1 January 2019, and 31 December 2022, all pre- and post-menopausal women diagnosed with recurrent, post-coital, and interstitial cystitis at both centers were included in the study. The main aim of the study was to assess the effectiveness of vaginal CO2 laser treatment, alone or combined with intravesical hyaluronic acid instillations, in managing cystitis symptoms, such as dysuria, pollakiuria, and urgency, across the entire patient cohort. The secondary objective was to investigate the reduction in number of annual cystitis episodes post-treatment. Methods: Each woman underwent three to four sessions of micro-ablative CO2 vaginal laser treatment. A follow-up examination was conducted 12 months after the final laser session (up to December 2023), during which a post-treatment VAS assessment evaluated dysuria, daily pollakiuria, and urgency. The enrolled patients recorded the number of cystitis episodes experienced during the 12-month pre- and post-treatment period. Results: Results indicated the laser's efficacy in reducing the total number of cystitis episodes per year and an improvement in symptoms up to one year post-treatment. Greater efficacy of the CO2 laser treatment, particularly when combined with intravesical hyaluronic acid instillation, was observed in both pre- and post- menopausal women. Conclusions: Fractional CO2 laser therapy represents a safe and efficacious, non-hormonal approach for pre- and post-menopausal women diagnosed with recurrent, post-coital, and interstitial cystitis. [ABSTRACT FROM AUTHOR]

The article discusses the features and prevalence of the SARS-CoV-2 KP.3 variant. The KP.3 variant is a descendant of the JN.1 lineage and is categorized as a variant under monitoring (VUM). It has been observed that the KP.3 variant is spreading globally, but with relatively low and variable concentrations. The article highlights the specific mutations present in the KP.3 variant, such as F456L, V1104L, and Q493E, and discusses their potential impact on the virus's ability to evade the immune system. However, the article emphasizes that there is currently no evidence to suggest that the KP.3 variant is a particularly concerning new variant. The authors stress the importance of continuous monitoring of SARS-CoV-2 variants to prevent unexpected outbreaks. [Extracted from the article]

The article discusses the avian influenza A (H7N5) outbreak and emphasizes the importance of not underestimating less famous subtypes of avian influenza. Avian influenza viruses are classified as highly pathogenic or low pathogenic based on the severity of the disease in poultry. While H7N5 is not commonly reported and has not been the center of significant outbreaks or public health concerns, continuous monitoring and research are essential to track potential mutations and the pathogenicity of these viruses. The article also highlights the need for robust surveillance, research, and preparedness strategies to mitigate the impact of highly genetically versatile viruses. [Extracted from the article]

This paper explores the potential of artificial intelligence, machine learning, and big data analytics in revolutionizing infection control. It addresses the challenges and innovative approaches in combating infectious diseases and antimicrobial resistance, emphasizing the critical role of interdisciplinary collaboration, ethical data practices, and integration of advanced computational tools in modern healthcare. [ABSTRACT FROM AUTHOR]

The recent WHO declaration of mpox (formerly known as monkeypox) as a Public Health Emergency of International Significance highlights the need for a coordinated response and addressing global inequalities in access to health resources. The study analyzes the genetic makeup of the newly emerged mpox lineage, Clade Ib, which has been found outside of Africa. The genetic analysis shows that Clade Ib is evolving more rapidly and has a lower mortality rate compared to the original Clade I lineage. Continued genome-based monitoring is crucial for tracking the evolution of mpox and developing predictive models for containment and management. [Extracted from the article]

The influenza A(H1N1) pdm09 virus, which emerged in 2009, has been circulating seasonally since then. In this study, we conducted a comprehensive genome-based investigation to gain a detailed understanding of the genetic and evolutionary characteristics of the hemagglutinin (HA) and neuraminidase (NA) surface proteins of A/H1N1pdm09 strains circulating in Italy over a fourteen-year period from 2009 to 2023 in relation to global strains. Phylogenetic analysis revealed rapid transmission and diversification of viral variants during the early pandemic that clustered in clade 6B.1. In contrast, limited genetic diversity was observed during the 2023 season, probably due to the genetic drift, which provides the virus with a constant adaptability to the host; furthermore, all isolates were split into two main groups representing two clades, i.e., 6B.1A.5a.2a and its descendant 6B.1A.5a.2a.1. The HA gene showed a faster rate of evolution compared to the NA gene. Using FUBAR, we identified positively selected sites 41 and 177 for HA and 248, 286, and 455 for NA in 2009, as well as sites 22, 123, and 513 for HA and 339 for NA in 2023, all of which may be important sites related to the host immune response. Changes in glycosylation acquisition/loss at prominent sites, i.e., 177 in HA and 248 in NA, should be considered as a predictive tool for early warning signs of emerging pandemics, and for vaccine and drug development. [ABSTRACT FROM AUTHOR]

The article discusses the emergence of Alaskapox, a newly discovered Orthopoxvirus that has caused skin lesions in infected patients. The virus was first discovered in 2015 and has been mainly isolated in people who have had contact with small wild mammals in Alaska. The severity of the disease can vary, with immunocompromised individuals being at greater risk of developing severe symptoms. Treatment options, such as antiviral therapy, are being explored. The genetic makeup of Alaskapox is unique compared to other known strains, and further investigation is needed to understand its origins and potential reservoirs. Data on individual cases are available for research purposes, and efforts are being made to automate data updates. [Extracted from the article]

Artificial intelligence (AI) and antimicrobial resistance (AMR) are two important challenges in global health. AI has the potential to improve disease diagnosis, treatment, and prevention, while AMR threatens our ability to effectively treat infections. Overuse and misuse of antibiotics have led to the emergence of bacterial resistance. AI can help diagnose antibiotic resistance more quickly and accurately, design new drugs, and analyze epidemiological data to predict outbreaks. However, there are challenges in training AI with limited data and implementing it in low-resource settings. Collaboration and a long-term vision are needed to make significant progress in managing AMR and preserving global health. [Extracted from the article]